Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Stephen Strickland

3 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Diagnostic

    ECOGHEMEAI141

    05/10/2016

    Early Assessment of Treatment Response in AML Using FLT PET/CT Imaging

    Treatment

    VICCHEM1553

    03/10/2016

    Phase II Trial of Vosaroxin in Combination with Infusional Cytarabine in Patients with Untreated AML

    Treatment

    VICCHEM1597

    02/17/2016

    A Phase 3 Open-label, Multicenter, Randomized Study of ASP2215 versus Salvage Chemotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with FLT3 Mutation


    Print this page for your doctor